The Innovative Next-Step in HIT Diagnostics
The next evolution in Heparin-Induced Thrombocytopenia (HIT) diagnostics, Versiti’s P-Selectin Expression Assay - PEA, will available for clinical order this December. When compared to the current ‘gold-standard’ SRA, the PEA is able to:
- detect more patients with HIT antibodies; and
- boasts a faster analytical time, resulting in an industry-leading TAT of <24 hours.
The Platelet and Neutrophil Immunology laboratory has over 25 years of experience performing advanced testing for HIT and is pleased to be on the forefront of innovation with the PEA.